Foster City, CA, United States of America

Guangnan Li

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Nkarta, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guangnan Li. Retrieved from https://idiyas.com/inventor/guangnan-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Immunotherapy by Guangnan Li

Introduction

Guangnan Li is an accomplished inventor based in Foster City, CA (US). He has made significant contributions to the field of cancer immunotherapy through his innovative research and development efforts. His work focuses on enhancing immune responses to combat cancer more effectively.

Latest Patents

Guangnan Li holds a patent titled "Methods for the Simultaneous Expansion of Multiple Immune Cell Types, Related Compositions and Uses of Same in Cancer Immunotherapy." This patent represents a breakthrough in the methods used to expand immune cell types, which can lead to more effective cancer treatments.

Career Highlights

Li is currently employed at Nkarta, Inc., a company dedicated to advancing cell therapy for cancer treatment. His role at Nkarta allows him to apply his expertise in immunology and cell expansion techniques to develop innovative therapies that can improve patient outcomes.

Collaborations

One of his notable collaborators is Daofeng Liu, with whom he has worked closely on various projects related to immune cell therapies. Their partnership has contributed to the advancement of research in this critical area of medicine.

Conclusion

Guangnan Li's contributions to cancer immunotherapy through his patent and work at Nkarta, Inc. highlight the importance of innovation in the fight against cancer. His efforts are paving the way for more effective treatments that can significantly impact patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…